NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-125359 | Pharmaceuticals and Healthcare
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Novel Drug Delivery Systems for Cancer Therapy Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET
7.1 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA NOVEL DRUG DELIVERY SYSTEMS FOR CANCER THERAPY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Advanced Medical Isotope Corporation
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Bind Therapeutics
16.3 Boston Scientific Corporation
16.4 BTG plc
16.5 CeloNova BioSciences Inc.
16.6 Cook Medical Inc.
16.7 Cospheric LLC
16.8 Covidien plc
16.9 Eckert & Ziegler BEBIG
16.10 EmboMedics Inc.
16.11 Kobo Products Inc.
16.12 Merit Medical Systems Inc.
16.13 Mo-Sci Corporation
16.14 Nanobiotix
16.15 Polysciences Inc.
16.16 Sirtex Medical Inc.
16.17 Terumo Corporation
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeEmbolization Particles ? Drug Eluting Beads
Polyvinyl Alcohol Particles
Microspheres
Gelatin-Based Embolization Devices
Selective Internal Radiation Therapy
Holmium-Based Microspheres
Liquid Embolics ? Onyx
By Application
Hospitals
Clinics
Companies
Advanced Medical Isotope Corporation
Bind Therapeutics
Boston Scientific Corporation
BTG plc
CeloNova BioSciences Inc.
Cook Medical Inc.
Cospheric LLC
Covidien plc
Eckert & Ziegler BEBIG
EmboMedics Inc.
Kobo Products Inc.
Merit Medical Systems Inc.
Mo-Sci Corporation
Nanobiotix
Polysciences Inc.
Sirtex Medical Inc.
Terumo Corporation
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.